Sun Pharma to acquire Innovcare Lifesciences for $28.7m

Sun Pharmaceutical Industries has agreed to purchase India-based Innovcare Lifesciences in a deal valued at approximately Rs2.71bn ($28.7m). Sun Pharma expects to close the acquisition on or before 31 July 2026. Following the conclusion of the deal, Sun Pharma will acquire full ownership and control of Innovcare Lifesciences. Credit: Nils Versemann / Shutterstock.com. Sun Pharmaceutical Industries has agreed to purchase India-based Innovcare Lifesciences in a deal valued at approximately Rs2.71bn ($28.7m). According to a regulatory filing, Sun Pharma will buy the entire issued and outstanding share capital of Innovcare Lifesciences via a cash transaction. The company expects to close the…

Source: Pharmaceutical Technology